XML 17 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (3,822) $ (1,872)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 217 18
Noncash interest expense 30 13
Change in fair value of warrant liability 17
Change in fair value of note payable (58)
Changes in operating assets and liabilities:    
Trade receivable (43) (228)
Prepaid expenses and other accounts receivable (943) (336)
Inventory 71 567
Trade payables (13) (21)
Other accounts payable and accrued expenses 357 586
Deferred revenue (175) (11)
Operating right-of-use asset 11
Operating lease liabilities (19)
Accrued severance pay, net (1)
Net cash used in operating activities (4,312) (1,343)
Cash flows from investing activities:    
Cash acquired in ENvue Merger 148
Purchase of property and equipment (17) (5)
Net cash (used in) provided by investing activities (17) 143
Cash flows from financing activities:    
Proceeds from the issuance of common stock, preferred stock and warrants, net 3,900
Repurchase of Series X Preferred Stock (1,560)
Proceeds from issuance of notes payable to related party 1,050
Net cash provided by financing activities 2,340 1,050
Effects of currency translation on cash and cash equivalents (1)
Net decrease in cash, cash equivalents and restricted cash (1,989) (151)
Cash, cash equivalents and restricted cash at beginning of period 4,254 752
Cash, cash equivalents and restricted cash at end of period 2,265 601
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 2,235 571
Restricted cash at end of period 30 30
Total cash, cash equivalents and restricted cash 2,265 601
Supplemental disclosures of cash flow information:    
Cash paid for interest
Cash paid for taxes $ 1